These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11804277)

  • 1. Apoptosis detected with monoclonal antibody to single-stranded DNA is a predictor of recurrence in intracranial meningiomas.
    Konstantinidou A; Korkolopoulou P; Patsouris E; Mahera H; Hranioti S; Kotsiakis X; Davaris P
    J Neurooncol; 2001 Oct; 55(1):1-9. PubMed ID: 11804277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of apoptotic cells in archival tissue from diffuse astrocytomas using a monoclonal antibody to single-stranded DNA.
    Korkolopoulou PA; Konstantinidou AE; Patsouris ES; Christodoulou PN; Thomas-Tsagli EA; Davaris PS
    J Pathol; 2001 Mar; 193(3):377-82. PubMed ID: 11241419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitosin, a novel marker of cell proliferation and early recurrence in intracranial meningiomas.
    Konstantinidou AE; Korkolopoulou P; Kavantzas N; Mahera H; Thymara I; Kotsiakis X; Perdiki M; Patsouris E; Davaris P
    Histol Histopathol; 2003 Jan; 18(1):67-74. PubMed ID: 12507285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas.
    Karamitopoulou E; Perentes E; Tolnay M; Probst A
    Hum Pathol; 1998 Feb; 29(2):140-5. PubMed ID: 9490273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA topoisomerase IIalpha expression correlates with cell proliferation but not with recurrence in intracranial meningiomas.
    Konstantinidou AE; Patsouris E; Korkolopoulou P; Kavantzas N; Mahera H; Davaris P
    Histopathology; 2001 Oct; 39(4):402-8. PubMed ID: 11683942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis in bladder carcinomas detected with monoclonal antibody to single-stranded DNA: relation to cell cycle regulators and survival.
    Korkolopoulou P; Konstantinidou AE; Christodoulou P; Patsouris E; Thomas-Tsangli E; Kapralos P; Davaris P
    Urology; 2000 Sep; 56(3):516-20. PubMed ID: 10962336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up.
    Lanzafame S; Torrisi A; Barbagallo G; Emmanuele C; Alberio N; Albanese V
    Pathol Res Pract; 2000; 196(7):483-8. PubMed ID: 10926326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated p53 expression in benign meningiomas protects against recurrence and may be indicative of senescence.
    Hakin-Smith V; Battersby RD; Maltby EL; Timperley WR; Royds JA
    Neuropathol Appl Neurobiol; 2001 Feb; 27(1):40-9. PubMed ID: 11299001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of apoptotic and proliferation markers in meningiomas.
    Konstantinidou AE; Pavlopoulos PM; Patsouris E; Kaklamanis L; Davaris P
    J Pathol; 1998 Nov; 186(3):325-30. PubMed ID: 10211124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p53, MDM2 protein and Ki-67 antigen in recurrent meningiomas.
    Ohkoudo M; Sawa H; Hara M; Saruta K; Aiso T; Ohki R; Yamamoto H; Maemura E; Shiina Y; Fujii M; Saito I
    J Neurooncol; 1998 May; 38(1):41-9. PubMed ID: 9540056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression.
    Abdelzaher E; El-Gendi SM; Yehya A; Gowil AG
    Br J Neurosurg; 2011 Dec; 25(6):707-13. PubMed ID: 20979437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptotic activity and bcl-2 immunoreactivity in meningiomas. Association with grade and outcome.
    Abramovich CM; Prayson RA
    Am J Clin Pathol; 2000 Jul; 114(1):84-92. PubMed ID: 10884803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caspase-3 immunohistochemical expression is a marker of apoptosis, increased grade and early recurrence in intracranial meningiomas.
    Konstantinidou AE; Givalos N; Gakiopoulou H; Korkolopoulou P; Kotsiakis X; Boviatsis E; Agrogiannis G; Mahera H; Patsouris E
    Apoptosis; 2007 Apr; 12(4):695-705. PubMed ID: 17143787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of candidate immunohistochemical prognostic markers of meningioma recurrence.
    Csonka T; Murnyák B; Szepesi R; Bencze J; Bognár L; Klekner A; Hortobágyi T
    Folia Neuropathol; 2016; 54(2):114-26. PubMed ID: 27543769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth rate of intracranial meningioma: tumor doubling time and proliferating cell nuclear antigen staining index.
    Ide M; Jimbo M; Yamamoto M; Umebara Y; Hagiwara S; Kubo O
    Neurol Med Chir (Tokyo); 1995 May; 35(5):289-93. PubMed ID: 7623949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features.
    Yang SY; Park CK; Park SH; Kim DG; Chung YS; Jung HW
    J Neurol Neurosurg Psychiatry; 2008 May; 79(5):574-80. PubMed ID: 17766430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the proliferating cell nuclear antigen and clinicopathological features in intracranial meningiomas.
    Kim CH; Cheong JH; Bak KH; Kim JM; Oh SJ
    J Clin Neurosci; 2001 May; 8 Suppl 1():44-8. PubMed ID: 11386825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis in breast carcinoma.
    González-Cámpora R; Galera Ruiz MR; Vázquez Ramírez F; Ríos Martín JJ; Fernández Santos JM; Ramos Martos MM; Gómez Pascual A
    Pathol Res Pract; 2000; 196(3):167-74. PubMed ID: 10729921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrences of meningiomas: predictive value of pathological features and hormonal and growth factors.
    Maiuri F; De Caro MB; Esposito F; Cappabianca P; Strazzullo V; Pettinato G; de Divitiis E
    J Neurooncol; 2007 Mar; 82(1):63-8. PubMed ID: 17225937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AKT2 expression in histopathologic grading and recurrence of meningiomas.
    Wang Q; Fan SY; Qian J; Wang JY; Lu YC; Hu GH; Luo C
    Eur J Surg Oncol; 2014 Sep; 40(9):1056-61. PubMed ID: 24656454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.